New FDA regulation of tobacco products has problems

New US legislation granting the Food and Drug Administration (FDA) jurisdiction over tobacco products represents a serious compromise on the part of tobacco control advocates, argues a new essay in this week's open access journal PLoS Medicine.

Stanton Glantz and colleagues from the University of California San Francisco say that the new policy is another example of legislative compromise with the tobacco industry that can lead to short-term public health gains at the expense of long-term progress.

The new policy repeals federal pre-emption of state and local regulation of tobacco advertising, which is a positive move, but it also allows the an opportunity to rehabilitate its image and products because they are now "FDA regulated," say the authors. That tobacco interests are represented on the Scientific Advisory Committee that plays a central role in the development of FDA regulations—violating the World Health Organization Framework Convention on Tobacco Control— will make it difficult to develop and implement effective regulation in the United States and beyond, say the authors.

The challenge moving forward, say the authors, will be for the compromise law's advocates "to accept responsibility for these problems and to see that their negative consequences do not materialize."

More information: Glantz SA, Barnes R, Eubanks SY (2009) Compromise or Capitulation? US Food and Drug Administration Jurisdiction Over Products. PLoS Med 6(7): e1000118. doi:10.1371/journal.pmed.1000118

Source: Public Library of Science (news : web)


Explore further

Regulation of tobacco products favors big tobacco, makes US farms less stable

Citation: New FDA regulation of tobacco products has problems (2009, July 28) retrieved 21 January 2022 from https://medicalxpress.com/news/2009-07-fda-tobacco-products-problems.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors